Previous studies assessed the usefulness of Lp(a) levels to predict atherosclerotic events; however, it is unknown if Lp(a) levels are increased in patients without underlying atherosclerosis but with risk to develop CAD or MI. This evidence concerns the gene LPA and coronary artery disorder.